Project Grant HT94252510634
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$400K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
This $385,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Wayne State University's research to develop therapeutic approaches targeting spiral ganglion-cochlear nucleus synaptopathy. The two-year award, running from September 1, 2023 to August 31, 2025, aims to transform health care for Service Members and the American public through innovative and impactful biomedical research. As a prominent public...
The Defense Health Agency awarded Wayne State University a $616,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to investigate the molecular mechanisms and therapeutic potential of the RNA methyltransferase FTSJ3 in regulating ribosome biogenesis in liver cancer. The project will be conducted over a 2-year period from September 30, 2023 to September 29, 2025. As a premier public research university, Wayne State University has a track record of...
This $924,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Wayne State University to target dual-specificity phosphatase 1 in platinum resistance in ovarian cancer. The award, which runs from July 1, 2024 to June 30, 2028, will enable Wayne State to conduct innovative scientific studies to improve treatment options and outcomes for this challenging form of cancer, which disproportionately impacts...
Wayne State University was awarded a $538,792 project grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Targeting TINAGL1 to Enhance Immunotherapy Response in Lung Cancer." The three-year award beginning May 1, 2023 will support the university's efforts to investigate medical solutions for battlefield injuries and transform military and public health care through innovative biomedical research....
The U.S. Department of Defense's Defense Health Agency awarded a $693,000 Project Grant to Wayne State University in Detroit, Michigan under the Military Medical Research and Development program (CFDA 12.420). The grant supports the university's "EPIGENETIC THERAPEUTIC TARGETING OF ENHANCER HUBS FOR BREAST CANCER" research project, which aims to develop new treatments for breast cancer. The 3-year award, running from December 15, 2023 to December 14, 2026, will fund basic,...
Wayne State University was awarded a $1,386,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant will fund a novel strategy targeting the metabolic vulnerability of castration-resistant prostate cancer (CRPC) from July 1, 2023 to June 30, 2026. Through this award, Wayne State University researchers will investigate medical solutions for prostate cancer by developing and applying an innovative approach focused on CRPC's...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Western Michigan University on the recovery of functional visual pathways in the adult mammalian brain using an alpha7 nicotinic acetylcholine receptor agonist after blast exposure. The $377,300 award, valid from September 15, 2023 to September 14, 2025, aims to investigate medical solutions for the battlefield and transform health care for service...
The U.S. Department of Defense's Defense Health Agency awarded a $643,558 Project Grant to Wright State University on August 12, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research on "IMMUNOTOXICANT EXPOSURES AND INDIVIDUALIZED IMMUNE MODULATION VIA VARIANTS" over a 3-year performance period ending on August 11, 2027. As a leading research university, Wright State University has extensive experience conducting biomedical...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,181,250.00 to The Ohio State University to conduct research on the use of MIF inhibition and glucocorticoid therapeutics as a synergistic treatment to promote neuronal survival in traumatic retinal injury. The research aims to develop novel therapies for this type of injury, which is of particular relevance to military personnel. The...
This Project Grant award from the Defense Health Agency provides $3.76 million to Washington State University for optimization and evaluation of photo-responsive microneedle arrays for sustained ocular drug delivery from June 1, 2023 to May 31, 2027. The award is being made under the Military Medical Research and Development program to investigate medical solutions for the battlefield and transform military and public health care. Washington State University will advance understanding of drug...